Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 75-79

  De Mello, Walmor C ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

ANF; Cardiomyopathic hamster; Cell communication; Failing heart

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; GUANYLATE CYCLASE; ZAPRINAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL COMMUNICATION; CONTROLLED STUDY; HEART CONDUCTION; HEART FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BUCLADESINE; CARDIOMYOPATHIES; CELL COMMUNICATION; CRICETINAE; CYCLIC GMP; ELECTROPHYSIOLOGY; GAP JUNCTIONS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; MALE; MESOCRICETUS; PHOSPHODIESTERASE INHIBITORS; PURINONES; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 0031746395     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00012     Document Type: Article

References (31)

1. Kirsch B. Electron microscopy of the atrium of the heart. Exp Med Surg 1956;14:99-112.
2. Jamieson JD, Palade GE. Specific granules in atrium muscle cells. J Cell Biol 1964;23:151-6.
3. de Bold AJ, Borenstein HB, Veress AT, Sonnenburg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981;28:89-94.
4. de Bold AJ. Atrial natriuretic factor, a hormone produced by the heart. Science 1985;230:767-70.
5. Cantin M, Thibault G, Haile-Meskel H, et al. Atrial natriuretic factor in the impulse-conduction system of the rat cardiac ventricles. Cell Tissue Res 1989;256:309-25.
6. Lattion AL, Michel JB, Aauld E, Corvol P, Soubrier F. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol 1986;25:H890-6.
7. Franch HA, Dixon RAF, Blaine EH, Siegl PKS. Ventricular atrial natriuretic factor in the cardiomyopathic hamster model of congestive heart failure. Circ Res 1988;62:31-6.
8. Nardo PD, Minieri M, Carbone A, et al. Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy. Mol Cell Biochem 1993;125:179-92.
9. Takemura G, Fujiwara H, Mukoyama M, et al. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1991;83:181-90.
10. Brenner BM, Ballerman BJ, Gunning ME, Ziedel ML. Diverse biological action of atrial natriuretic peptide. Physiol Rev 1990;70:665-99.
11. Koller PT, Nicklas JM, Di Carlo LA, Shenker Y, Grekin RY. Marked elevation of plasma atrial natriuretic factor during paroxysmal atrial tachycardia. Circulation 1985;III:102A.
12. Yamaji T, Ishibashi M, Nakaoka H, Imataka K, Amono M, Fujii Y. Possible role of atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet 1985;1:1211.
13. Weismand HF, Weinfeldt ML. Toward an understanding of the molecular basis of cardiomyopathies. J Am Cell Cardiol 1987;10:1135-8.
14. De Mello WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension 1996;27:1267-72.
15. Powell T, Twist T. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 1976;72:327-33.
16. Tanigushi Y, Kokubun S, Noma A, Irisawa H. Spontaneously active cells isolated from the sinoatrial and atrioventricular node of the rabbit heart. Jpn J Physiol 1981;31:547-58.
17. Imura R, Sano T, Goto J, Yamada K, Matsuda Y. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl-cyclase-linked receptors. Mol Pharmacol 1992;42:982-90.
18. Smith JB, Lincoln TM. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol 1987:253(Cell Physiol 22):C147-50.
19. Burns F, Rodger IW, Pyne NJ. The catalytic subunit of protein kinase A triggers activation of the type V cyclic-GMP-specific phosphodiesterase from guinea-pig lung. Biochem J 1992; 283:487-91.
20. Rapoport RM, Ginsburg R, Waldman SA, Murad F. Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro. Eur J Pharmacol 1986;124:193-9.
21. Yiang H, Colbran YL, Francis SH, Corbin YD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 1992;254:H1206-13.
22. Burt Y, Spray DC. Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol 1988; 254:H1206-11.
23. Kwak BR, Saez JC, Wilders R, et al. Effect of c-GMP dependent phosphorylation on rat and human connexin43 gap junction channels. Pflugers Arch 1995;430:770-8.
24. Graham RM, Zisfein JB. Atrial natriuretic factor; biosynthetic regulation and role in circulatory homeostasis. In: Fozzard H, Jennings RB, Haber E, et al. eds. The heart and cardiovascular system. New York: Raven Press, 1986:1559-69.
25. Winaver Y, Hoffman A, Abassi Z, Haramati A. Does the heart failure hormone, ANP, help in congestive heart failure? News in Physiologic Sci 1995;10:247-53.
26. Winaver J, Hoffman A, Beuett JC, Haramati A. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988;254:R776-84.
27. Margulies KB, Perrela MA, Mckinley LJ, Buett YC. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. J Clin Invest 1991;88:1636-42.
28. Ichii Y, Kawashima E, Kawabe J, Kikuchi K. Secretion of atrial natriuretic factor from the left ventricle and heart in patients with hypertrophic cardiomyopathy: relationship with hemodynamic and echocardiographic profiles. J Cardiol 1997;30:19-28.
29. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 1992;44:479-87.
30. Lochner A, Genade S, Mouton R. Massive atrial natriuretic peptide (ANP) release in ischemia reperfusion. Cardiovasc Drugs Ther 1992;6:447-58.
31. Keckemeti V, Pacher P, Pankucsi C, Nanasi P. Comparative study of cardiac electro-physiologic effects of atrial natriuretic peptide. Mol Cell Biochem 1996;160:53-9.